A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface - Wikidata - wikimedia - TriplyDB

A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface

A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface

http://www.wikidata.org/entity/Q27681319

about

Shake, rattle, and roll: Impact of the dynamics of flavivirus particles on their interactions with the host Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus Rapid isolation of dengue-neutralizing antibodies from single cell-sorted human antigen-specific memory B-cell cultures Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope Recent advances in understanding dengue Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to DENV4 Infection and Vaccination Protective Capacity of the Human Anamnestic Antibody Response during Acute Dengue Virus Infection Structural Basis for Recognition of Human Enterovirus 71 by a Bivalent Broadly Neutralizing Monoclonal Antibody Dengue: knowledge gaps, unmet needs, and research priorities The Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and Immunoprophylaxis Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection.Temperature-dependent folding allows stable dimerization of secretory and virus-associated E proteins of Dengue and Zika viruses in mammalian cells.Dissecting the human serum antibody response to secondary dengue virus infections Virus-like particle secretion and genotype-dependent immunogenicity of dengue virus serotype 2 DNA vaccine Evaluation of protection induced by a dengue virus serotype 2 envelope domain III protein scaffold/DNA vaccine in non-human primates.Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional groups of antibody clones.Variation of the specificity of the human antibody responses after tick-borne encephalitis virus infection and vaccination.A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus.Reverse Engineering of Vaccine Antigens Using High Throughput Sequencing-enhanced mRNA Display A new quaternary structure epitope on dengue virus serotype 2 is the target of durable type-specific neutralizing antibodies.DENGUE VIRUS. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers Functional Transplant of a Dengue Virus Serotype 3 (DENV3)-Specific Human Monoclonal Antibody Epitope into DENV1.A game of numbers: the stoichiometry of antibody-mediated neutralization of flavivirus infection.Plasmablasts During Acute Dengue Infection Represent a Small Subset of a Broader Virus-specific Memory B Cell Pool.Conformational changes in intact dengue virus reveal serotype-specific expansion.Epitope Addition and Ablation via Manipulation of a Dengue Virus Serotype 1 Infectious Clone Recent advances in understanding the adaptive immune response to Zika virus and the effect of previous flavivirus exposure.Low frequency of broadly neutralizing HIV antibodies during chronic infection even in quaternary epitope targeting antibodies containing large numbers of somatic mutations.Immune correlates of protection for dengue: State of the art and research agenda.Vaccines licensed and in clinical trials for the prevention of dengue.Genetic epidemiology of dengue viruses in phase III trials of the CYD tetravalent dengue vaccine and implications for efficacy Complexity of Human Antibody Response to Dengue Virus: Implication for Vaccine Development.Principles of Broad and Potent Antiviral Human Antibodies: Insights for Vaccine Design.Immunization with Immune Complexes Modulates the Fine Specificity of Antibody Responses to a Flavivirus Antigen.Functional analysis of dengue virus (DENV) type 2 envelope protein domain 3 type-specific and DENV complex-reactive critical epitope residues.Modeling the Role of Epitope Arrangement on Antibody Binding Stoichiometry in Flaviviruses.Analysis of Individuals from a Dengue-Endemic Region Helps Define the Footprint and Repertoire of Antibodies Targeting Dengue Virus 3 Type-Specific Epitopes.Epitope-associated and specificity-focused features of EV71-neutralizing antibody repertoires from plasmablasts of infected children.

P2860

Q23925011-9447AD7A-C2B7-40F4-AEBF-B679F9D3AE3F Q26247258-0692F527-850C-4424-9C9C-60D4B18CAC2F Q26700070-5739F97E-2089-4AAD-9F42-2B56F9DB5B72 Q26700120-90E74CCA-B42E-480D-9052-EE71C936D565 Q26766156-8DAA15C3-039E-4A22-9626-D7515085684A Q28114614-2FE38E3B-FDC0-486F-B8B8-732ECD3A3DC7 Q28119679-1CE3303E-9626-4D24-9C62-0B3ECC571CE8 Q28550496-E3807CE2-A362-47FC-8FC3-6F6E16766E90 Q28729764-C132424F-137A-4C3A-A6A9-696D3B354BB8 Q28804225-E76EFE21-DB56-49D9-ABA8-E1DFABDB344E Q30250932-F0371BBE-B4EA-490E-A252-DF9D6E02D9A4 Q33425879-96D9AF83-9132-4A6A-8DEC-96D5C2562D0B Q33681310-6823D27C-0D67-4780-B345-242CB6AC049F Q33728716-B78CE917-8726-4486-98BB-C78E79A876DE Q34262245-B77E3362-3DD9-48DB-B46B-8458CD2460FB Q34522384-05AF36AE-1A0C-4A16-805C-67750B0BAF6D Q34593818-C027D0A4-ADDC-4691-8139-0DD536FB3E64 Q34594111-3DD01BC7-37E5-43C7-BAEE-8F2C26E9C9E2 Q35138111-894821D7-84A0-4C61-86F2-8BBB7182A622 Q35654743-BAC823EC-C122-43D4-8CD0-79F950948A6E Q35794740-167968FB-DA90-49CB-A08B-592EE5E6ADB7 Q36205859-84F21A02-C348-4023-ABEB-3328FC2A1DD8 Q36352752-DE86B6A8-AE07-4381-A9E7-ADCA9AE56411 Q36878970-9C6E8BAE-0EE7-47B5-8048-645A9120ACC9 Q37012203-E67A7983-2B51-4BF7-A5AC-1F43E86F1421 Q37363501-23765AE2-3E44-40E8-9E79-A7674E221F75 Q37642687-F689CA6F-69C1-4AEE-9F91-AB37187DEC02 Q37661008-73AF4072-1F86-41BA-BA25-D1B09EC1F325 Q38158407-0910D985-3746-4371-BC28-4CEE59204D1D Q38589314-04608F08-A7A7-4769-AC7F-83920BA79A55 Q38652971-88F151C3-E916-4E33-B07B-F8741E57E3F2 Q39172722-19394B97-DEB0-4195-BB61-9DC1C7BDDDD0 Q39375868-5101E435-DE45-44BD-9AC9-574C427B53B4 Q39535403-1295F25A-9B45-431C-AFD2-3401142699DF Q40043685-DC03C46F-D050-4BAC-BC01-7C6459EFB0E7 Q40154194-B5D5C05B-7BEE-482A-A1E7-FA32A4963F3D Q40185205-1D7C3460-995F-4365-BA1B-41E17168ACE6 Q40530597-3D85096B-8889-4139-B3D1-B053C0312512 Q41676281-E8B751F1-4E25-4D40-9CAB-01912493AE47 Q41925938-AAA865B4-155A-4856-B034-7AD43B6BC9B4

P2860

A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface

http://www.wikidata.org/entity/Q27681319

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

A potent anti-dengue human ant ...... assembled on the virus surface

@ast

A potent anti-dengue human ant ...... assembled on the virus surface

@en

A potent anti-dengue human ant ...... assembled on the virus surface

@nl

type

label

A potent anti-dengue human ant ...... assembled on the virus surface

@ast

A potent anti-dengue human ant ...... assembled on the virus surface

@en

A potent anti-dengue human ant ...... assembled on the virus surface

@nl

prefLabel

A potent anti-dengue human ant ...... assembled on the virus surface

@ast

A potent anti-dengue human ant ...... assembled on the virus surface

@en

A potent anti-dengue human ant ...... assembled on the virus surface

@nl

P1433

Q27681319-68999831-FDA3-4BDE-83DB-36A3B0F29C9C

P1476

Q27681319-22C0B577-D891-42FA-B4D9-D9072742E022

P2093

Q27681319-245F687F-14B2-4574-9085-A32F4B7C24B8

Q27681319-35A12FC9-92E3-488D-82D1-E93B278DCADC

Q27681319-3E134799-4BB8-48F8-8890-B75A29D8FB95

Q27681319-9CB5CC1D-0595-4810-87A9-5578B82A7770

Q27681319-E832B6C2-39C5-429C-B595-D288EF25ACC9

Q27681319-EFD345D7-8021-49A5-9E99-40F4E946D512

Q27681319-F0F95C26-03B6-4BD6-9F15-CC52DCE40C77

P2860

Q27681319-0E942231-D035-4FD7-96BB-C0FA4AAE2AC9

Q27681319-14B80A22-DF49-40E4-8874-266F7D9E070F

Q27681319-16AD0EDE-F328-4BB1-8119-C52C04659578

Q27681319-2047A5AC-3B93-498E-9159-60977CD2FC2D

Q27681319-24BD1C52-6CEC-47AF-8118-5DC470C39C96

Q27681319-2626F3B8-59AA-4C58-A644-C599FE6ACE15

Q27681319-2841417F-D905-4D0F-84E2-01AEC09A511A

Q27681319-2AA7F0A6-2B67-47BC-82A5-66D6D147BF19

Q27681319-2B46D0A6-E06F-4C45-A866-497BAC1BD9E6

Q27681319-2C0CD6B8-790D-4763-8C64-99900DDA066F

P304

Q27681319-8D59EE55-3C1C-4EB1-81E7-B4CC57E025FB

P31

Q27681319-0A9BB6B0-F7CE-446F-977A-E83171EB2C23

P3181

Q27681319-FD742F13-E213-4EFE-AE45-06DFB0FBF718

P356

Q27681319-C499BD14-10BF-4F7D-B255-DF292393C896

P433

Q27681319-CCB8CDA8-8FE0-4E67-8AD4-130C1DD512A4

P478

Q27681319-AA0C481A-E330-402F-8AB1-06716BB8BF6E

P50

Q27681319-2814AE5D-7C22-49F7-BE34-B0B48993CDB3

Q27681319-73B92ED3-9B08-4F57-B8B8-BDB5F3F34468

Q27681319-8A3217D1-F483-43C6-9485-4C6F18FDEF84

Q27681319-9AA9065B-7A28-4E94-87FD-C1CD599DC7A9

Q27681319-AC54CBD2-D76B-434F-BD35-23E8BEC1924B

P577

Q27681319-19830BFA-4C7F-4B89-B9E0-1FA1C6D40258

P5875

Q27681319-C7FC1493-85D8-40CF-85CC-E146FA8078FA

P698

Q27681319-9D7C5BC2-CFF9-4E4D-9B93-8B6F18FF0C66

P921

Q27681319-34054A28-6CC9-41B6-BEA2-BDDFAE8C2FDD

Q27681319-738D339C-B1DA-4B0C-9304-83064B65A502

P932

Q27681319-021906D6-0A9F-4B9A-AA42-0161C049C0A8

P3181

P356

P1433

EMBO Molecular Medicine

P1476

A potent anti-dengue human ant ...... assembled on the virus surface

@en

P2093

Adamberage R de Alwis

http://www.w3.org/2001/XMLSchema#string

Jiaqi Wang

http://www.w3.org/2001/XMLSchema#string

Joanne L Tan

http://www.w3.org/2001/XMLSchema#string

Kristie D Ibarra

http://www.w3.org/2001/XMLSchema#string

Scott A Smith

http://www.w3.org/2001/XMLSchema#string

Shee-Mei Lok

http://www.w3.org/2001/XMLSchema#string

Thiam-Seng Ng

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular biology of flaviviruses

Electrostatics of nanosystems: application to microtubules and the ribosome

The global distribution and burden of dengue

Structure of dengue virus: implications for flavivirus organization, maturation, and fusion

Improved methods for building protein models in electron density maps and the location of errors in these models

Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification

Serotype-specific detection of dengue viruses in a fourplex real-time reverse transcriptase PCR assay.

A ligand-binding pocket in the dengue virus envelope glycoprotein

Comparison of Plaque- and Flow Cytometry-Based Methods for Measuring Dengue Virus Neutralization

Epitope Determinants of a Chimpanzee Dengue Virus Type 4 (DENV-4)-Neutralizing Antibody and Protection against DENV-4 Challenge in Mice and Rhesus Monkeys by Passively Transferred Humanized Antibody

P304

358-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3132380

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/EMMM.201303404

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Victor A Kostyuchenko

Aravinda de Silva

James E. Crowe Jr.

Guntur Fibriansah

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259722218

http://www.w3.org/2001/XMLSchema#string

P698

24421336

http://www.w3.org/2001/XMLSchema#string

P921

P932

3958310

http://www.w3.org/2001/XMLSchema#string